Discussion Part II: Pharmacology

Discussion Part II: Pharmacology

To prepare:

Read the following article to enhance your knowledge of commonly prescribed medications:

Kalil, A., & Bailey, K. L. (2014, October 20). Septic shock medication. Retrieved from http://emedicine.medscape.com/article/168402-medication

All of the following groups of medications are commonly prescribed in the acute care setting. Choose one of the topics below to discuss. If it is a medication group, select a specific drug within that group. (This is a good way for you to prepare for clinical practice, because you will get to know the drugs you will prescribe for patients.). Focus your discussion on the hospital or ICU setting and IV usage.

All of the following groups of medications are commonly prescribed in the acute care setting. This Discussion will focus on CABG patients. Choose one of the topics below to discuss in terms of management of a post-CABG patient. Focus your discussion on the hospital or ICU setting and IV usage.

1. Norepinephrine

Note: When sharing your initial post, select a drug that has not yet been discussed. If all drugs have been discussed, then you may select that drug again.

By Day 3

For this Discussion, address 1 of the following options:

Option 1

Post a description of a patient you have taken care of (inpatient as an RN, or as an NP student) who has been prescribed the medication you selected. Include the scenario, indication, dosing, complications, and outcome. Then explain whether or not you would have ordered the same drug and same dose.

Option 2

Conduct an evidence-based drug search on the drug you selected and post an explanation of any possible issues. Are there any drug interactions? Any black box warnings? To what type of patient would you prescribe this medication?

Option 3

Post an explanation of the properties of the drug you selected, including usages and dosing in the hospital or ICU. Describe a patient to whom you would prescribe this medication.

Note: To be considered as one of your required responses, your pharmacology rationale must include a supporting reference.

Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the “Post to Discussion Question” link and then select “Create Thread” to complete your initial post. Remember, once you click on Submit, you cannot delete or edit your own posts, and you cannot post anonymously. Please check your post carefully before clicking on Submit!

Submission and Grading Information

Grading Criteria

ANSWER

Bev Pharmacology

Option 3

Coronary artery bypass graft Surgery continues to be embraced by medical practitioners for treatment of diseases associated with coronary artery. Being part of an acute care setting in hospitals, management of post CABG patients requires selection of a good drug that should be used in the right dosage for complete recovery after an operation (Harskamp et al., 2013). This essay looks at Norepinephrine drug by considering its usage and dosage in a hospital setting as well as describing a patient that can have the dug administered.

Properties of 1-Norepinephrine

1-Norepinephrine naturally occurs as a catecholamine hormone that acts as a neurotransmitter in the naval system. It stimulates receptors such as adrenergic directly into the blood stream. It is used when the blood pressure is low resulting from surgery such as one for CABG (Park et al., 2015). The drug is administered as an injection commonly into a patient’s large vein. The drug has no specific dosage but rather it is administered as long as it takes until the patient responds to medication. Some receive it for many days others may be fine after a short while. The care giver has to check the blood pressure as well as general breathing to ensure the patient is stable.

Patient to whom the drug is prescribed

The drug can be prescribed to patients who have an extremely low blood pressure (hypotension) or those who have had shock which sometimes arise as a result of cardiac operations. In such a case, it is therefore administered as a post-surgery measure. The drug is mostly administered in ICU or in hospitals during emergency settings as an injection in the vei…

References

Harskamp, R. E., Lopes, R. D., Baisden, C. E., de Winter, R. J., & Alexander, J. H. (2013). Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Annals of surgery, 257(5), 824-833.

Park, S. J., Ahn, J. M., Kim, Y. H., Park, D. W., Yun, S. C., Lee, J. Y., … & Choo, S. J. (2015). Trial of everolimus-eluting stents or bypass surgery for coronary disease. New England Journal of Medicine, 372(13), 1204-1212.